Home
ABT
ABT News

Latest Abbott Laboratories (ABT) News on December 21, 2024

MT Newswires

18 hours ago

TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $130, Keeps Buy Rating

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

Zacks

a day ago

The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories

4 Healthcare Technology Innovators to Invest in Before the New Year

Zacks

2 days ago

4 Healthcare Technology Innovators to Invest in Before the New Year

Reasons to Retain ABT Stock in Your Portfolio Now

Zacks

2 days ago

Reasons to Retain ABT Stock in Your Portfolio Now

2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond

Motley Fool

2 days ago

2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond

ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker

Zacks

3 days ago

ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker

MT Newswires

3 days ago

RBC Raises Price Target on Abbott Laboratories to $135 From $130, Keeps Outperform Rating

The Smartest Dividend Stocks to Buy With $500 Right Now

Motley Fool

3 days ago

The Smartest Dividend Stocks to Buy With $500 Right Now

Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know

Zacks

3 days ago

Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know

Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta

CNW Group

3 days ago

Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta

Are Abbott Laboratories' (NYSE:ABT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.

4 days ago

Are Abbott Laboratories' (NYSE:ABT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart

PR Newswire

4 days ago

Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart

MT Newswires

5 days ago

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $132 From $134, Maintains Buy Rating

Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns

GuruFocus.com

8 days ago

Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns

PBH or ABT: Which Is the Better Value Stock Right Now?

Zacks

8 days ago

PBH or ABT: Which Is the Better Value Stock Right Now?

Abbott Increases Quarterly Dividend for 53rd Consecutive Year

PR Newswire

8 days ago

Abbott Increases Quarterly Dividend for 53rd Consecutive Year

MT Newswires

9 days ago

Nephron Adjusts Price Target on Abbott Laboratories to $120 From $118

On Ozempic? Big Food Makers Have a New Label for You

The Wall Street Journal

9 days ago

On Ozempic? Big Food Makers Have a New Label for You

Big Food’s Latest Label: GLP-1 Friendly

The Wall Street Journal

9 days ago

Big Food’s Latest Label: GLP-1 Friendly

Abbott (ABT) Stock Sinks As Market Gains: Here's Why

Zacks

9 days ago

Abbott (ABT) Stock Sinks As Market Gains: Here's Why

Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories

GuruFocus.com

10 days ago

Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories

Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth?

Insider Monkey

11 days ago

Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth?

Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness

Simply Wall St.

12 days ago

Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness

University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott

PR Newswire

13 days ago

University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

15 days ago

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet

Zacks

16 days ago

Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Simply Wall St.

16 days ago

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Zacks

17 days ago

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Zacks

21 days ago

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

Zacks

22 days ago

Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Simply Wall St.

22 days ago

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems

Zacks

22 days ago

The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems

Top Research Reports for Abbott, BlackRock & ConocoPhillips

Zacks

24 days ago

Top Research Reports for Abbott, BlackRock & ConocoPhillips

ABT Stock Benefits From First Patient Procedures With TAVI System

Zacks

24 days ago

ABT Stock Benefits From First Patient Procedures With TAVI System

Unlocking Intrinsic Value: Analysis of Abbott Laboratories

GuruFocus.com

24 days ago

Unlocking Intrinsic Value: Analysis of Abbott Laboratories

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

GlobeNewswire

25 days ago

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis

PR Newswire

a month ago

Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis

Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company

Simply Wall St.

a month ago

Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 78% of the company

2 Dividend Kings to Buy for a Lifetime of Passive Income

Motley Fool

a month ago

2 Dividend Kings to Buy for a Lifetime of Passive Income

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Zacks

a month ago

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?

Zacks

a month ago

Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

a month ago

Inside a $400 billion bet on the brain-computer interface revolution

Argus Research

a month ago

Weekly Stock List

Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now

Insider Monkey

a month ago

Abbott Laboratories (ABT): A Magnificent Dividend Growth Stock to Buy Now

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

Motley Fool

a month ago

3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years

US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024

Medical Device Network

a month ago

US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024

Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories

GuruFocus.com

a month ago

Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories

Abbott Laboratories (NYSE:ABT) shareholders have earned a 8.6% CAGR over the last five years

Simply Wall St.

a month ago

Abbott Laboratories (NYSE:ABT) shareholders have earned a 8.6% CAGR over the last five years

Is Abbott Laboratories' (NYSE:ABT) Recent Stock Performance Influenced By Its Financials In Any Way?

Simply Wall St.

a month ago

Is Abbott Laboratories' (NYSE:ABT) Recent Stock Performance Influenced By Its Financials In Any Way?

If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?

Benzinga

a month ago

If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?

The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE

Zacks

a month ago

The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

Motley Fool

a month ago

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

Top Stock Reports for Amazon.com, Procter & Gamble & Abbott

Zacks

a month ago

Top Stock Reports for Amazon.com, Procter & Gamble & Abbott

Abbott Laboratories (ABT) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era

Insider Monkey

a month ago

Abbott Laboratories (ABT) Makes It On UBS’ List Of Stocks For The AI, Growth & Low Rates Era

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution

Simply Wall St.

2 months ago

Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution

Abbott price target raised to $149 from $143 at Barclays

TipRanks

2 months ago

Abbott price target raised to $149 from $143 at Barclays

Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now?

Insider Monkey

2 months ago

Is Abbott Laboratories (ABT) the Best Pharma Stock to Buy Right Now?

MT Newswires

2 months ago

Barclays Adjusts Price Target on Abbott Laboratories to $149 From $143

MT Newswires

2 months ago

Barclays Adjusts Abbott Laboratories Price Target to $149 From $143

Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial

Investor's Business Daily

2 months ago

Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial

Abbott, Reckitt found not liable in baby formula case. Stocks rise.

Yahoo Finance Video

2 months ago

Abbott, Reckitt found not liable in baby formula case. Stocks rise.

Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win

Investopedia

2 months ago

Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win

Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win

The Wall Street Journal

2 months ago

Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win

Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case

Just Food

2 months ago

Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case

Abbott shares rise after securing first win in premature infant formula trial

Reuters

2 months ago

Abbott shares rise after securing first win in premature infant formula trial

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Simply Wall St.

2 months ago

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up

Reckitt Shares Surge After Baby Formula Lawsuit Win

The Wall Street Journal

2 months ago

Reckitt Shares Surge After Baby Formula Lawsuit Win

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win

The Wall Street Journal

2 months ago

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win

Investing.com

2 months ago

Reckitt, Abbott surge after winning an NEC case

Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight

GuruFocus.com

2 months ago

Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight

New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management

CNW Group

2 months ago

New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management

Beyond Market Price: Uncovering Abbott Laboratories's Intrinsic Value

GuruFocus.com

2 months ago

Beyond Market Price: Uncovering Abbott Laboratories's Intrinsic Value

ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock

Zacks

2 months ago

ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock

3 Dividend Growth Stocks You Can Buy and Hold Forever

Motley Fool

2 months ago

3 Dividend Growth Stocks You Can Buy and Hold Forever

HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View

Zacks

2 months ago

HCA Healthcare Beats on Q3 Earnings, Reaffirms 2024 EPS View

Abbott initiates clinical trial of its CardioMems in advanced heart failure

TipRanks

2 months ago

Abbott initiates clinical trial of its CardioMems in advanced heart failure

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Simply Wall St.

2 months ago

Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)

Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums

Zacks

2 months ago

Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums

Community Health Q3 Earnings Miss on Lower Adjusted Admissions

Zacks

2 months ago

Community Health Q3 Earnings Miss on Lower Adjusted Admissions

MT Newswires

2 months ago

Abbott Laboratories Launches Clinical Study of Early Heart Pump Intervention in Heart Failure

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

PR Newswire

2 months ago

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

MT Newswires

2 months ago

Abbott Laboratories Insider Sold Shares Worth $18,424,298, According to a Recent SEC Filing

Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment

Insider Monkey

2 months ago

Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment

Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt

Zacks

2 months ago

Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt

MT Newswires

2 months ago

Daiwa Securities Adjusts Price Target on Abbott Laboratories to $125 From $120

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Top Research Reports for Visa, Netflix & Merck

Zacks

2 months ago

Top Research Reports for Visa, Netflix & Merck

MT Newswires

2 months ago

Argus Adjusts Price Target on Abbott Laboratories to $145 From $135

Argus Research

2 months ago

Analyst Report: Abbott Laboratories

Argus Research

2 months ago

Market Digest: ABT, KEY, MAN, NFLX, PPG, BMI

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

Motley Fool

2 months ago

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever

Abbott Laboratories (ABT): Strong Q2 Performance and Innovative Product Approvals

Insider Monkey

2 months ago

Abbott Laboratories (ABT): Strong Q2 Performance and Innovative Product Approvals

Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?

Zacks

2 months ago

Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?

Abbott Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

2 months ago

Abbott Laboratories Third Quarter 2024 Earnings: EPS Beats Expectations

3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now

Motley Fool

2 months ago

3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now

Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic

Benzinga

2 months ago

Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic

MT Newswires

2 months ago

Abbott Laboratories Strategizing 'Price Wars' With CGM Flexibility, Oppenheimer Says

MT Newswires

2 months ago

Abbott Laboratories' Q3 Results Show Strength of Diversified Business Model, RBC Says

Abbott reports sales of $10.6bn for Q3 2024

Medical Device Network

2 months ago

Abbott reports sales of $10.6bn for Q3 2024

Share on Social Networks: